PO.2.48 Incomplete systemic lupus erythematosus: clinical and immunological manifestations

PO.2.48 Incomplete systemic lupus erythematosus: clinical and immunological manifestations

Bibliographic Details
Main Authors:	E Nasonov, A Lila, T Panafidina, T Popkova, Y Gorbunova, L Kondrateva
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

LP-048 Characteristics and clinical outcome of incomplete systemic lupus erythematosus
by: Anastasiia Shumilova, et al.
Published: (2023-07-01)

LP-199 Medications given to patients with incomplete systemic lupus erythematosus
by: Anastasiia Shumilova, et al.
Published: (2023-07-01)

PO.3.65 The leptin and adiponectin levels in patients with systemic lupus erythematosus and their relationship with cardiovascular risk factors
by: T Panafidina, et al.
Published: (2022-10-01)

PO.4.85 What are the sex differences in patients with systemic lupus erythematosus?
by: T Panafidina, et al.
Published: (2022-10-01)

PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
by: M Aristova, et al.
Published: (2022-10-01)

LP-026 Obesity, hyperleptinemia and insulin resistance in women with systemic lupus erythematosus and rheumatoid arthritis
by: Yulia Gorbunova, et al.
Published: (2023-07-01)

LP-027 Overweight and obesity phenotypes based on body mass index and insulin resistance in women with systemic lupus erythematosus
by: Yulia Gorbunova, et al.
Published: (2023-07-01)

Clinical significance of leptin in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2021-12-01)

Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic
by: E. L. Nasonov, et al.
Published: (2021-05-01)

HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES
by: T. A. Panafidina, et al.
Published: (2018-07-01)

The clinical and laboratory manifestations of systemic lupus erythematosus
by: Natalia Gennadyevna Klyukvina, et al.
Published: (2012-12-01)

Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
by: T A Panafidina, et al.
Published: (2008-05-01)

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01)

Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
by: E. L. Nasonov, et al.
Published: (2021-09-01)

LP-203 The new markers of systemic lupus erythematosus activity: focus on interleukin (IL)-1b and soluble IL-2 receptor
by: Mariia Aristova, et al.
Published: (2023-07-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Systemic lupus erythematosus – the discrepancy between renal impairment and clinical and immunological manifestations
by: Mihaela-Ruxandra Dragusin, et al.
Published: (2023-03-01)

Obesity and overweight phenotypes in patients with systemic lupus erythematosus based on body mass index and serum leptin levels: a pilot cross-sectional study
by: L. V. Kondratyeva, et al.
Published: (2022-07-01)

PO.2.30 IGG/IGM autoantibody ratios do not relate to progression from incomplete systemic lupus erythematosus to systemic lupus erythematosus
by: H Bootsma, et al.
Published: (2022-10-01)

Genetic load in incomplete lupus erythematosus
by: Joseph M Kheir, et al.
Published: (2023-01-01)

PO.2.46 Clinical and immunological considerations of ceruloplasmin activity shifts in systemic lupus erythematosus
by: A Trofimenko, et al.
Published: (2022-10-01)

Systemic lupus erythematosus: new horizons for diagnosis and therapy
by: S. K. Solovyev, et al.
Published: (2020-02-01)

Monitoring patients with systemic lupus erythematosus: general characteristics and discussion questions (according to the Canadian Rheumatology Association recommendations)
by: T. A. Panafidina, et al.
Published: (2019-07-01)

PO.2.42 The value of IGA-ACL and IGA-AB2-GP1 in clinical and laboratory manifestations of systemic lupus erythematosus
by: T Reshetnyak, et al.
Published: (2022-10-01)

Soluble CD40 Ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection
by: T V Popkova, et al.
Published: (2008-05-01)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)

Clinical and immunological manifestations of systemic lupus erythematosus: A study on 146 south Tunisian patients
by: Jallouli Moez, et al.
Published: (2008-01-01)

Lupus panniculitis as an initial manifestation of systemic lupus erythematosus
by: Patel Raksha, et al.
Published: (2010-01-01)

Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus
by: Haitao Yu, et al.
Published: (2021-06-01)

ROLE OF INFLAMMATION MARKERS IN DEVELOPMENT OF ATHEROSCLEROSIS AND ITS COMPICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Tatiyana Valentinovna Popkova, et al.
Published: (2014-02-01)

Role of inflammation in the development of cardiac autonomic disfunction in patients with systemic lupus erythematosus
by: D. S. Novikova, et al.
Published: (2008-12-01)

Insulin resistance and type 2 diabetes mellitus risk factors in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2021-09-01)

The clinical course and standard therapy of systemic lupus erythematosus in the Russian Federation
by: E. L. Nasonov, et al.
Published: (2016-06-01)

Clinical manifestations, courses, and outcomes of systemic lupus erythematosus in the dwellers of Kyrgyzstan
by: G. M. Koilubaeva, et al.
Published: (2016-10-01)

Analyses of the clinical and immunological characteristics of patients with lupus erythematosus
by: Min Deng, et al.
Published: (2022-01-01)

Lupus Enteritis: An Unusual Manifestation of Systemic Lupus Erythematosus
by: Dr. Amitra Ramrattan
Published: (2023-01-01)

Metabolic syndrome in patients with systemic lupus erythematosus
by: T Y Popkova, et al.
Published: (2008-08-01)

PO.2.36 Characterization of peripheral blood b-cell subset in untreated patients with systemic lupus erythematosus
by: T Popkova, et al.
Published: (2022-10-01)

Respiratory Manifestations in Systemic Lupus Erythematosus
by: Salvatore Di Bartolomeo, et al.
Published: (2021-03-01)

Discoid lupus erythematosus with genital manifestations
by: Samia Mrabat, et al.
Published: (2021-04-01)